(DECEMBER 16, 2022) A Pfizer RSV vaccine for pregnant women is in phase 3 trial, with the potential to help infants cope with the sometimes serious illness, according to WCAX-TV. “If infants can be born with some immunity,” says pediatric critical care physician Rebecca Bell, M.D., associate professor of pediatrics, “even if it’s short-lived, even if it’s six months or one year, that can make a huge difference in terms of kids’ health.” (Click headline for more.)
Rebecca Bell, M.D.
(DECEMBER 16, 2022) A Pfizer RSV vaccine for pregnant women is in phase 3 trial, with the potential to help infants cope with the sometimes serious illness, according to WCAX-TV. “If infants can be born with some immunity,” says pediatric critical care physician Rebecca Bell, M.D., associate professor of pediatrics, “even if it’s short-lived, even if it’s six months or one year, that can make a huge difference in terms of kids’ health.”